← Leaderboards
Gerald T Nepom
Benaroya Research Inst At Virginia Mason
$318,570,989
Attributed
$318,570,989
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $60.6M · FY2005–22$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$318,570,989 · 12
By mechanism
UM1$307,126,378 · 1
U19$4,813,741 · 2
R01$2,850,248 · 1
R21$1,844,250 · 3
P01$1,352,287 · 3
P30$584,085 · 1
Top collaborators
No co-investigators on record.
Most similar at Benaroya Research Inst At Virginia Mason
Same institution · by research overlap
- Jane Hoyt Buckner$93,413,622
- Carmen R Mikacenic$5,918,794
- Matthew C. Altman$2,143,970
Others in their field
Top investigators on “Autoimmunity”
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Mark S Anderson · University Of California, San Francisco$69,470,335
- Robert S Negrin · Stanford University$48,464,292
- Lynette Keyes-Elstein · Rho Federal Systems Division, Inc.$41,304,871
Research focus
AutoimmunityClinical ResearchResearch PersonnelDesignResponseProgramsImmunologyImmunologicsAreaAutoantigensNational Institute Of Allergy And Infectious DiseaseStructureAutoimmune DiseasesHuman SubjectImmune ToleranceUniversitiesOrgan FailureResearch InstituteClinical Research SiteResourcesMhc Class Ii AntigenResearch DesignAdoptedDrug Withdrawal
Grant awards (51)
Immune Tolerance Network$28,845,822
UM1 · FY2022 · AI · contact PI
Immune Tolerance Network$4,831,165
UM1 · FY2022 · AI · contact PI
Immune Tolerance Network$29,550,346
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$19,793,297
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$4,500,000
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$3,229,811
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$2,300,000
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$1,255,142
UM1 · FY2021 · AI · contact PI
Immune Tolerance Network$29,419,000
UM1 · FY2020 · AI · contact PI
Immune Tolerance Network$30,170,000
UM1 · FY2019 · AI · contact PI
Immune Tolerance Network$29,600,000
UM1 · FY2018 · AI · contact PI
Immune Tolerance Network$29,448,000
UM1 · FY2017 · AI · contact PI
Immune Tolerance Network$31,901,976
UM1 · FY2016 · AI · contact PI
Immune Tolerance Network$31,949,949
UM1 · FY2015 · AI · contact PI
Core E: Immunology and Inflammation Core$192,341
P30 · FY2015 · DK · contact PI
Immune Tolerance Network$30,331,870
UM1 · FY2014 · AI · contact PI
Core E: Immunology and Inflammation Core$192,443
P30 · FY2014 · DK · contact PI
Core E: Immunology and Inflammation Core$199,301
P30 · FY2013 · DK · contact PI
Checkpoints and Autoimmune Homeostasis in T1D$563,760
U19 · FY2011 · AI · contact PI
Checkpoints and Autoimmune Homeostasis in T1D$487,539
U19 · FY2010 · AI · contact PI
Checkpoints and Autoimmune Homeostasis in T1D$491,073
U19 · FY2009 · AI · contact PI
HLA Susceptibility Genes in Rheumatoid Arthritis$290,779
R01 · FY2009 · AR · contact PI
Checkpoints and Autoimmune Homeostasis in T1D$689,022
U19 · FY2008 · AI · contact PI
HLA Susceptibility Genes in Rheumatoid Arthritis$290,779
R01 · FY2008 · AR · contact PI
HLA Susceptibility Genes in Rheumatoid Arthritis$183,000
R01 · FY2008 · AR · contact PI
Checkpoints and Autoimmune homeostasis in T1D$1,250,132
U19 · FY2007 · AI · contact PI
HLA Susceptibility Genes in Rheumatoid Arthritis$296,713
R01 · FY2007 · AR · contact PI
CD4+ T CELL PROFILES IN IDDM$260,098
P01 · FY2007 · DK · contact PI
Checkpoints and Autoimmune homeostasis in T1D$1,332,215
U19 · FY2006 · AI · contact PI
HLA Susceptibility Genes in Rheumatoid Arthritis$305,574
R01 · FY2006 · AR · contact PI
CD4+ T CELL PROFILES IN IDDM$264,131
P01 · FY2006 · DK · contact PI
MHC tetramers for epitopes of B anthracis PA$351,000
R21 · FY2005 · AI
HLA Susceptibility Genes in Rheumatoid Arthritis$312,928
R01 · FY2005 · AR
CD4+ T CELL PROFILES IN IDDM$256,440
P01 · FY2005 · DK
MHC tetramers for epitopes of B anthracis PA$351,000
R21 · FY2004 · AI
Treatment/Type 1 Diabetes/hGAD65 Altered Peptide Ligand$438,750
R21 · FY2003 · DK
HLA SUSCEPTIBILITY GENES IN RHEUMATOID ARTHRITIS$302,765
R01 · FY2003 · AR
Treatment/Type 1 Diabetes/hGAD65 Altered Peptide Ligand$420,000
R21 · FY2002 · DK
HLA SUSCEPTIBILITY GENES IN RHEUMATOID ARTHRITIS$295,868
R01 · FY2002 · AR
ALLELE SPECIFIC TRANSCRIPTIONAL CONTROL OF HLA DQ EXPRESSION$180,000
P01 · FY2002 · DK
Autoantigen-specific T cells in IDDM$0
U19 · FY2002 · AI
HLA SUSCEPTIBILITY GENES IN RHEUMATOID ARTHRITIS$289,172
R01 · FY2001 · AR
MODULATION OF A DIABETES GENE BY VIRAL TRANSACTIVATION$141,750
R21 · FY2001 · DK
TARGETED INACTIVATION OF ARTHRITIS ASSOCIATED GENES$0
N01 · FY2001 · AR
Autoantigen-specific T cells in IDDM$0
U19 · FY2001 · AI
ALLELE SPECIFIC TRANSCRIPTIONAL CONTROL OF HLA DQ EXPRESSION$0
P01 · FY2001 · DK
HLA SUSCEPTIBILITY GENES IN RHEUMATOID ARTHRITIS$282,670
R01 · FY2000 · AR
PEPTIDE-BASED IMMUNOMODULATION OF IDDM$212,500
P01 · FY2000 · DK
ALLELE SPECIFIC TRANSCRIPTIONAL CONTROL OF HLA DQ EXPRESSION$179,118
P01 · FY2000 · DK
MODULATION OF A DIABETES GENE BY VIRAL TRANSACTIVATION$141,750
R21 · FY2000 · DK
TARGETED INACTIVATION OF ARTHRITIS ASSOCIATED GENES$0
N01 · FY2000 · AR